自噬在膀胱癌发展和治疗中的研究进展

陈诗; 付什; 谭智勇; 王剑松; 王海峰

doi:10.12259/j.issn.2095-610X.S20230503

自噬在膀胱癌发展和治疗中的研究进展

doi: 10.12259/j.issn.2095-610X.S20230503

昆明医科大学第二附属医院泌尿外科/云南省泌尿系统疾病临床医学中心，云南昆明　650101

基金项目: 国家自然科学基金资助项目（81660422，81860452）

详细信息

作者简介:
陈诗（1992～），男，湖北宜昌人，在读硕士研究生，住院医师，主要从事膀胱癌基础研究工作

通讯作者:
王海峰，E-mail：wanghaifeng@kmmu.edu.cn

中图分类号: R737.14
计量
- 文章访问数: 3952
- HTML全文浏览量: 2176
- PDF下载量: 28
- 被引次数: 0
出版历程
- 收稿日期: 2023-01-01
- 网络出版日期: 2023-05-12
- 刊出日期: 2023-05-25

Research Progress of Autophagy in the Development and Treatment of Bladder Cancer

Dept. of Urology，The 2nd Affiliated Hospital of Kunming Medical University，Yunnan Urinary System Disease Clinical Medical Center，Kunming Yunnan 650101，China

摘要

摘要: 自噬是细胞通过溶酶体降解细胞内物质的一种自我消化过程，被认为是肿瘤在应激条件下维持生存的重要保护机制。大量证据表明，自噬是一把双刃剑，通过不同的信号通路，既可抑制肿瘤的发生，又可促进肿瘤的存活与生长。因此，越来越多的学者认为自噬有望成为肿瘤治疗的新策略。通过总结自噬调控膀胱癌侵袭、转移等生物学行为，以及在膀胱癌治疗的最新进展，以期为靶向自噬抗肿瘤药物的研发和治疗提供新的思路。
- 膀胱癌 /
- 自噬 /
- 肿瘤治疗 /
- 耐药
Abstract: Autophagy is a self-digestive process of cells degrading intracellular substances through lysosomes and is considered to be an important protection mechanism for tumors to maintain survival under stress conditions. A large number of evidence shows that autophagy is a double-edged sword, which can suppress the occurrence of tumors and promote the survival and growth of tumors by different signaling pathways. Therefore, more and more scholars believe that autophagy is expected to become a new strategy for tumor treatment. This paper summarizes the biological behavior of autophagy regulation of bladder cancer invasion, metastasis, and the latest progress in the treatment of bladder cancer and provides new ideas for the development and treatment of autophagy-targeted antitumor drugs.
- Bladder cancer /
- Autophagy /
- Tumor therapy /
- Drug resistance

HTML全文

表 1 自噬与膀胱癌发展

Table 1. Autophagy and the development of bladder cancer

靶标	信号通路	自噬状态	肿瘤调控
砷	不确定	自噬缺陷	肿瘤发生
Rab14	MAPK/ERK	抑制	肿瘤发生
MIR-516A	PHLPP2/BECN1	抑制	肿瘤发生
低营养	TGF-β1/Smad3	激活	上皮间质转化
MIR-21	不确定	抑制	上皮间质转化
缺氧	不确定	激活	血管生成
肿瘤微环境	PI3K/AKT	激活	血管生成
顺铂	BECN1	激活	化疗耐药
吡柔比星	p70S6K/4E-BP1	激活	化疗耐药
IFN-γ	JAK2/STAT3	激活	干性维持
ATG7	USP28/CD44	激活	干性维持
NBR1	Not determined	激活	免疫逃逸
ATG7	FOXO3a/miR-145/PD-L1	激活	免疫逃逸

下载: 导出CSV

表 2 膀胱癌中的靶向自噬治疗

Table 2. Targeted autophagy therapy in bladder cancer

类型	治疗物质	自噬状态	调控作用	测试细胞系
天然活性物质	没食子酸酯	激活	凋亡	T24.5637
	桦木酸	激活	凋亡	T24.EJ
	灵菌红素	抑制	化疗敏感	RT-112
小分子化合药	罗帕洛酸	激活	凋亡	T24.J82
	甲磺酸	抑制	化疗敏感	5637.HT1197
	厄达替尼	激活	凋亡	T24.UMUC-3
非编码RNA	MIR-24-3p	激活	肿瘤发展	T24.BIU-87
	MIR-222	抑制	化疗敏感	T24.5637
	ADAMTS9-AS2	激活	凋亡	5637.UM-UC-3
其他	重组腺病毒	激活	凋亡	T24.5637.EJ
	重组精氨酸酶	激活	凋亡	T24.5637.J82

下载: 导出CSV

参考文献(38)

[1]	Siegel R L,Miller K D,Jemal A. Cancer statistics,2020[J]. CA:A Cancer Journal for Clinicians,2020,70(1):7-30. doi: 10.3322/caac.21590
[2]	Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians,2021,71(3):209-249. doi: 10.3322/caac.21660
[3]	Birgisdottir A B,Johansen T. Autophagy and endocytosis - interconnections and interdependencies[J]. Journal of Cell Science,2020,133(10):1-16.
[4]	Rakesh R,Priyadharshini L C,Sakthivel K M,et al. Role and regulation of autophagy in cancer[J]. Biochimica Et Biophysica Acta Molecular Basis of Disease,2022,1868(7):1-22.
[5]	Li W,He P,Huang Y,et al. Selective autophagy of intracellular organelles: Recent research advances[J]. Theranostics,2021,11(1):222-256. doi: 10.7150/thno.49860
[6]	Kim J,Kundu M,Viollet B,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J]. Nature Cell Biology,2011,13(2):132-141. doi: 10.1038/ncb2152
[7]	MizushimaI N,Komatsu M. Autophagy: Renovation of cells and tissues[J]. Cell,2011,147(4):728-741. doi: 10.1016/j.cell.2011.10.026
[8]	Li X,He S,Ma B. Autophagy and autophagy-related proteins in cancer[J]. Molecular Cancer,2020,19(1):1-16. doi: 10.1186/s12943-019-1085-0
[9]	Towers C G,Wodetzki D,Thorburn A. Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations[J]. The Journal of Cell Biology,2020,219(1):1-15.
[10]	Ishaq M,Ojha R,Sharma A P,et al. Autophagy in cancer: Recent advances and future directions[J]. Seminars In Cancer Biology,2020,66(11):171-181.
[11]	Lee C H,Yu H S. Role of mitochondria,ROS,and DNA damage in arsenic induced carcinogenesis[J]. Frontiers in Bioscience,2016,8(2):312-320. doi: 10.2741/s465
[12]	Denisenko T V,Gogvadze V,Zhivotovsky B. Mitophagy in carcinogenesis and cancer treatment[J]. Discover Oncology,2021,12(1):1-11. doi: 10.1007/s12672-021-00395-9
[13]	Chao H,Deng L,Xu F,et al. RAB14 activates MAPK signaling to promote bladder tumorigenesis[J]. Carcinogenesis,2019,40(11):1341-1351. doi: 10.1093/carcin/bgz039
[14]	Jin H,Ma J,Xu J,et al. Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy[J]. Autophagy,2021,17(4):840-854. doi: 10.1080/15548627.2020.1733262
[15]	Tong H,Yin H,Hossain M A,et al. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation[J]. Journal of Cellular Biochemistry,2019,120(4):5118-5127. doi: 10.1002/jcb.27788
[16]	Zhang H H,Huang Z X,Zhong S Q,et al. MiR-21 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line[J]. International Journal of Oncology,2020,56(4):986-998.
[17]	Gubbiotti M A,Buraschi S,Kapoor A,et al. Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy[J]. Seminars in Cancer Biology,2020,62(1):1-8.
[18]	Li D,Jiao W,Liang Z,et al. Variation in energy metabolism arising from the effect of the tumor microenvironment on cell biological behaviors of bladder cancer cells and endothelial cells[J]. Bio Factors,2020,46(1):64-75. doi: 10.1002/biof.1568
[19]	Li X,Wei Z,Yu H,et al. Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis[J]. Cancer Letters,2021,523(12):10-28.
[20]	Lin J F,Lin Y C,Tsai T F,et al. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells[J]. Drug Design,Development and Therapy,2017,11(5):1517-1533.
[21]	Li K,Chen X,Liu C,et al. Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells[J]. Biochemical and Biophysical Research Communications,2015,460(2):380-385. doi: 10.1016/j.bbrc.2015.03.042
[22]	Ojha R,Singh S K,Bhattacharyya S. JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells[J]. Biochimica Et Biophysica Acta,2016,1860(11):2484-2497. doi: 10.1016/j.bbagen.2016.07.021
[23]	Ojha R,Jha V,Singh S K. Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells[J]. Biochimica Et Biophysica Acta,2016,1863(2):347-359. doi: 10.1016/j.bbamcr.2015.12.002
[24]	Zhu J,Huang G,Hua X,et al. CD44s is a crucial ATG7 downstream regulator for stem-like property,invasion,and lung metastasis of human bladder cancer (BC) cells[J]. Oncogene,2019,38(17):3301-3315. doi: 10.1038/s41388-018-0664-7
[25]	Yamamoto K,Venida A,Yano J,et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I[J]. Nature,2020,581(7806):100-105. doi: 10.1038/s41586-020-2229-5
[26]	Alissafi T,Hatzioannou A,Mintzas K,et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells[J]. The Journal of Clinical Investigation,2018,128(9):3840-3852. doi: 10.1172/JCI120888
[27]	Zhu J,Li Y,Luo Y,et al. A feedback loop formed by ATG7/autophagy,FOXO3a/miR-145 and PD-L1 regulates stem-like properties and invasion in human bladder cancer[J]. Cancers,2019,11(3):1-19.
[28]	Yin Z,Li J,Kang L,et al. Epigallocatechin-3-gallate induces autophagy-related apoptosis associated with LC3B II and Beclin expression of bladder cancer cells[J]. Journal of Food Biochemistry,2021,45(6):1-8.
[29]	Zhang Y,He N,Zhou X,et al. Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells[J]. Aging,2021,13(17):21251-21267. doi: 10.18632/aging.203441
[30]	Berning L,Schlutermann D,Friedrich A,et al. Prodigiosin sensitizes sensitive and resistant urothelial carcinoma cells to cisplatin treatment[J]. Molecules,2021,26(5):1-17.
[31]	Hung S Y,Chen W F,Lee Y C,et al. Rhopaloic acid A induces apoptosis,autophagy and MAPK activation through ROS-mediated signaling in bladder cancer[J]. Phytomedicine:International Journal of Phytotherapy and Phytopharmacology,2021,92(11):1-15.
[32]	Jimenez-Guerrero R,Gasca J,Flores M L,et al. Obatoclax and paclitaxel synergistically induce apoptosis and overcome paclitaxel resistance in urothelial cancer cells[J]. Cancers,2018,10(12):1-17.
[33]	Jin Y Y,Tong S Q,Tong M. Erdafitinib exerts the anticancer effect on urothelial carcinoma via induction of authophagy[J]. Die Pharmazie,2020,75(5):195-197.
[34]	Yu G,Jia Z,Dou Z. miR-24-3p regulates bladder cancer cell proliferation,migration,invasion and autophagy by targeting DEDD[J]. Oncology Reports,2017,37(2):1123-1131. doi: 10.3892/or.2016.5326
[35]	Zeng L P,Hu Z M,Li K,et al. miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells[J]. Journal of Cellular and Molecular Medicine,2016,20(3):559-567. doi: 10.1111/jcmm.12760
[36]	Zhang Z,Jia J P,Zhang Y J,et al. Long noncoding RNA ADAMTS9-AS2 inhibits the proliferation,migration,and invasion in bladder tumor cells[J]. OncoTargets and Therapy,2020,13(7):7089-7100.
[37]	Shang C,Zhu Y L,Li Y Q,et al. Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models[J]. Investigational New Drugs,2021,39(4):949-960. doi: 10.1007/s10637-021-01073-x
[38]	Zhao Z,Zhang P,Li W,et al. Pegylated recombinant human arginase 1 induces autophagy and apoptosis via the ROS-activated AKT/mTOR pathway in bladder cancer cells[J]. Oxidative Medicine and Cellular Longevity,2021,2021(3):1-13.

相关文章(20)

[1]	刘玉芹, 杨明莹, 王留芳, 夏斯亚, 李丹娜, 赵喜娟, 王娅. 膀胱癌患者报告结局量表的编制与信效度检验, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240727
[2]	安义均, 余立丹, 赵美素, 马冬梅, 杨春花, 孔瑶. 膀胱癌溶酶体相关基因的预后模型构建与分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240510
[3]	谢峻, 刘绍有, 施鸿金, 毛秋玉, 杨宏. EZH2抑制剂与膀胱癌GC化疗药物联用增敏的作用研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231017
[4]	张紫微, 郑甲林, 许晓宇, 王红. 二甲双胍通过AMPK/PPAR-γ通路诱导自噬抑制高糖对血管平滑肌细胞的增殖作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231026
[5]	张雪莎, 周杰, 李彩琳, 吴定宇, 彭芳. 美洲大蠊提取物对肝癌皮下移植瘤裸鼠自噬和侵袭转移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231018
[6]	梁晨晨, 高建鹏. MSCs通过调控AMPK/mTOR促进自噬改善NASH肝损伤, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230728
[7]	金晓媚, 何杰艳, 施吉昌, 邢辉, 王洪, 张桔, 董莉娟, 黄丽花, 陈敏, 陈志娟, 陈会超. 大理白族自治州2018年HIV/AIDS病毒基因型和抗病毒治疗前耐药研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231123
[8]	陈怡璇, 王琳, 夏秀宏, 彭在坤, 丁奕, 史润娇, 雷学芬. 自噬在肝细胞癌中的作用机制研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230416
[9]	顾君, 何泽喜, 栾婷, 王海峰, 王剑松, 丁明霞. 外泌体长链非编码RNA在膀胱癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220110
[10]	严植, 郝金钢, 尚芸芸. VI-RADS评分对膀胱癌精准治疗的价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220322
[11]	刘永骏, 王颖, 杨眉, 殷娥高, 李婷, 董昭兴. 氢气水调控自噬对百草枯中毒大鼠肺纤维化的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210918
[12]	孙文婧, 胡曼婷, 李娜, 葛菲, 陈文林, 刘洋. 乳腺癌内分泌治疗耐药及其逆转的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210724
[13]	杨灿, 巩宇航, 王海峰, 李海皓, 刘靖宇, 王伟, 王剑松, 左毅刚, 陈戬, 詹辉, 丁明霞. 单抗KMP1的体内抑制膀胱癌EJ细胞株成瘤的动物实验, 昆明医科大学学报.
[14]	雷玉英, 高洁, 王饶祥, 钏莉雪, 郝金钢. 弥散加权成像在膀胱癌诊断的价值, 昆明医科大学学报.
[15]	黄振华, 石鑫, 王辉涛, 张劲松, 王光, 郝金刚, 刘建和. 磁共振弥散加权成像在膀胱癌T分期的应用价值, 昆明医科大学学报.
[16]	廉阳秧. 中晚期宫颈癌组织HIF-1α、Twist、MDR1的表达及意义, 昆明医科大学学报.
[17]	王洋. RNA干扰CCR7表达在肿瘤转移治疗中的作用, 昆明医科大学学报.
[18]	曾红静. 蛋氨酸补偿代谢途径及蛋氨酸酶抗肿瘤研究进展, 昆明医科大学学报.
[19]	马真. 改良型TAT-VP3融合蛋白对膀胱癌BIU-87细胞Bcl-2和Survivin表达的影响, 昆明医科大学学报.
[20]	. 肌层浸润性膀胱癌的治疗策略, 昆明医科大学学报.